-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
rel-Zotatifin
Category | SARS-CoV |
CAS | 2098191-54-7 |
Description | Zotatifin is an eIF4A inhibitor. rel-Zotatifin is the racemic isomer of Zotatifin, acts as an eIF4A inhibitor with activity less than Zotatifin. |
Product Information
Synonyms | rel-eFT226; Zotatifin |
Molecular Weight | 487.55 |
Molecular Formula | C28H29N3O5 |
Canonical SMILES | CN(C)CC1C(C2(C(C1O)(C3=C(N=C(C=C3O2)OC)OC)O)C4=CC=C(C=C4)C#N)C5=CC=CC=C5 |
Purity | ≥98% (HPLC) |
Solubility | In vitro: 10 mM in DMSO |
Appearance | Off-white to light yellow (Solid) |
Storage | Store at 2-8°C |
Complexity | 819 |
Exact Mass | 487.21072103 |
Target | Eukaryotic Initiation Factor (eIF); SARS-CoV; Apoptosis |
XLogP3-AA | 2.4 |